Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Amann

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|April 13, 2017
Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanomaV C Amann, D Hoffmann, J Mangana, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 8, 2016
Developments in targeted therapy in melanomaV C Amann, E Ramelyte, S Thurneysen, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|April 13, 2017
Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanomaV C Amann, D Hoffmann, J Mangana, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 8, 2016
Developments in targeted therapy in melanomaV C Amann, E Ramelyte, S Thurneysen, et al.
Pageof 1